iRhythm (NASDAQ: IRTC) crashed 31% on Friday — the day's biggest loser — after a weak Q3 report and a delay to its next-gen heart monitor.
📉 Shares closed at $90.22, down from $130.19, after hitting a new 52-week low of $86.30
💰 Q3 revenue of $221.6M came in below the $222.2M Wall Street expected
⏳ Its Zio MCT device FDA filing is now pushed to 2027
📊 Volume exploded to 5.66M shares vs a 619K average
🏦 Wells Fargo cut its price target to $135 from $150
#iRhythm #IRTC #Stocks #Earnings #StockMarket #Healthcare #Zimbuck
📉 Shares closed at $90.22, down from $130.19, after hitting a new 52-week low of $86.30
💰 Q3 revenue of $221.6M came in below the $222.2M Wall Street expected
⏳ Its Zio MCT device FDA filing is now pushed to 2027
📊 Volume exploded to 5.66M shares vs a 619K average
🏦 Wells Fargo cut its price target to $135 from $150
#iRhythm #IRTC #Stocks #Earnings #StockMarket #Healthcare #Zimbuck
109 Visualizações
